IMV Inc.  Banner Image

IMV Inc.

  • Ticker IMV
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
IMV Inc.  Logo Image
  • 51-200 Employees
  • Based in Dartmouth, Nova Scotia
IMV Inc. is a clinical-stage immuno-oncology company dedicated to making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV's proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. Lead product candidateMore DPX-Survivac is currently being evaluated in several clinical trials in advanced ovarian cancer in combination with other innovative immunotherapy agents.
IMV Inc.

Most Recent Annual Report

IMV Inc.
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports